Arthur M. Cohen & Associates LLC Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Arthur M. Cohen & Associates LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,541 shares of the medical equipment provider’s stock after purchasing an additional 201 shares during the quarter. Intuitive Surgical makes up 1.0% of Arthur M. Cohen & Associates LLC’s portfolio, making the stock its 19th biggest holding. Arthur M. Cohen & Associates LLC’s holdings in Intuitive Surgical were worth $5,221,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ISRG. Norges Bank purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $2,401,493,000. GAMMA Investing LLC increased its stake in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock worth $14,999,630,000 after acquiring an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC increased its stake in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Capital Research Global Investors increased its stake in Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $313,769,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.1%

ISRG opened at $557.95 on Thursday. The business has a fifty day moving average of $519.52 and a 200 day moving average of $538.95. Intuitive Surgical, Inc. has a 52-week low of $405.08 and a 52-week high of $616.00. The stock has a market cap of $199.98 billion, a P/E ratio of 87.04, a PEG ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the topic of a number of research reports. Barclays reduced their price objective on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Evercore ISI reduced their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 23rd. Citigroup reaffirmed a “buy” rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Royal Bank of Canada reduced their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Finally, Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $596.05.

Insider Activity at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director now owns 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 489 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $533.18, for a total value of $260,725.02. Following the transaction, the senior vice president now owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. The trade was a 18.95% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 25,716 shares of company stock worth $12,831,288 in the last quarter. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.